Precigen, Inc. Common Stock(PGEN)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$3.65
52-Week Range
$1.38 – $5.46
YTD
-14.84%
IV Rank (30D)
19.51
Straddle Price
$0.68
P/C Vol Ratio
0.24
Market Cap
$1.3B
Fair Value
-50.0% vs price
Confidence: 13% Alpha Score: 0.48

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.49%
Beta vs SPY1.00
Cost of Equity (CAPM)9.99% (VRP-adj)
WACC9.59%
Volatility Risk Premium+83.2pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+30.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-1894.8%
Book / Price1.8%
Gross Margin (TTM)80.1%
FCF Margin (TTM)-370.2%
Debt / Equity4.62
Quality Score2/6 — normal (10y DCF)
SMA 50$4.09 (Market Anchor value)
SMA 20 / Bollinger Mid$4.17
Bollinger Width / SMA20556.4% (drives anchor stability)
Net Debt$0.1B
Market Cap$1B
Peers used for multiples: ALKS, AMGN, GILD, REGN, RVMD, TVTX, TWST, VRTX
Blended Fair Value
$0.56
Current Price
$3.67
Deviation
-50.0%
Forward-Return Rank SHORT gated
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -1.7% +0.66 -1.40 2.2%
42d +1.2% +2.06 -1.40 2.2%
63d +1.4% +1.77 -1.40 2.2%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 23.9× · 5 peers
Peer EV/EBITDA n/a 0% median 18.5× · 6 peers
Peer P/B $0.54 50% median 8.5× · 8 peers
Peer P/S $0.59 50% median 5.4× · 7 peers
Market Anchor (SMA50) $4.09 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-08 · updated 2026-06-08 19:22:08.278000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$1.3B

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. I…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan -1.30% 6
Feb +0.43% 6
Mar -3.64% 6
Apr +1.62% 6
May +1.08% 6
Jun -3.83% 6
Jul +4.07% 5
Aug +10.83% 5
Sep -17.36% 5
Oct -9.05% 5
Nov -1.08% 5
Dec +2.30% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $4.14
SMA 50: $4.08
SMA 200: $4.02
Current: $3.65
EMA 12: $3.97
EMA 26: $4.06
MACD: -0.0938 | Signal: -0.0872
BEARISH
ADX (14): 20.39
WEAK TREND
+DI: 19.42
−DI: 30.00
Momentum Oscillators
RSI (14): 38.28
NEUTRAL
Stoch %K: 11.31
Stoch %D: 11.15
Williams %R: -87.60
Volume & Volatility
BB Upper: $4.67
BB Lower: $3.61
NEUTRAL
OBV: 227,776,402
Vol SMA 20: 4,670,645
Vol ROC: 79.36%
ATR: $0.26
True Range: $0.17
HV 20: 70.3%
HV 30: 63.9%
HV 60: 86.0%

Data Summary
Data Points: 500
Last Updated: 2026-06-08T19:20:22.845000
Date Range: 2024-06-07T00:00:00 – 2026-06-05T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Options Activity
IV Rank (30D)
19.51
IV Rank (7D)
40.69
Avg IV
122.8%
Straddle (30D)
$0.68
Straddle (7D)
$0.50
P/C Volume
0.24
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.46
Correlation (SPY)
17.1%
0.03
Ann. Volatility
103.9%
SPY Volatility
12.1%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 317,719,196 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

202 filers134,035,298 shares$517.15M value42.19% of float
# Filer Shares Value % of Total % of Float Period
1 Patient Capital Management, LLC 17,817,387 $68.95M 13.33% 5.61% 2026-03-31
2 BlackRock, Inc. Custodian 15,223,191 $58.91M 11.39% 4.79% 2026-03-31
3 VANGUARD GROUP INC Custodian 10,479,452 $43.80M 8.47% 3.30% 2025-12-31
4 STATE STREET CORP 10,890,124 $42.14M 8.15% 3.43% 2026-03-31
5 Diametric Capital, LP 6,801,788 $26.32M 5.09% 2.14% 2026-03-31
6 Point72 Asset Management, L.P. 6,644,361 $25.71M 4.97% 2.09% 2026-03-31
7 TANG CAPITAL MANAGEMENT LLC 6,417,500 $24.84M 4.80% 2.02% 2026-03-31
8 GEODE CAPITAL MANAGEMENT, LLC Custodian 4,613,429 $17.86M 3.45% 1.45% 2026-03-31
9 Occam Crest Management LP 4,269,051 $16.52M 3.19% 1.34% 2026-03-31
10 IRIDIAN ASSET MANAGEMENT LLC/CT 3,592,730 $13.90M 2.69% 1.13% 2026-03-31
11 Boxer Capital Management, LLC 3,500,000 $13.54M 2.62% 1.10% 2026-03-31
12 MORGAN STANLEY Custodian 3,193,523 $13.35M 2.58% 1.01% 2025-12-31
13 GOLDMAN SACHS GROUP INC Custodian 3,350,477 $12.97M 2.51% 1.05% 2026-03-31
14 CITADEL ADVISORS LLC Custodian 2,702,383 $10.46M 2.02% 0.85% 2026-03-31
15 FRANKLIN RESOURCES INC Custodian 2,633,780 $10.19M 1.97% 0.83% 2026-03-31
16 FMR LLC Custodian 1,998,596 $7.73M 1.50% 0.63% 2026-03-31
17 JANE STREET GROUP, LLC Custodian 1,821,790 $7.05M 1.36% 0.57% 2026-03-31
18 NORTHERN TRUST CORP Custodian 1,611,790 $6.24M 1.21% 0.51% 2026-03-31
19 BANK OF AMERICA CORP /DE/ Custodian 1,471,279 $5.69M 1.10% 0.46% 2026-03-31
20 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,460,620 $5.65M 1.09% 0.46% 2026-03-31
21 Woodline Partners LP 1,401,412 $5.42M 1.05% 0.44% 2026-03-31
22 PRELUDE CAPITAL MANAGEMENT, LLC 1,270,053 $4.92M 0.95% 0.40% 2026-03-31
23 Corient Private Wealth LLC 911,206 $3.53M 0.68% 0.29% 2026-03-31
24 ADAGE CAPITAL PARTNERS GP, L.L.C. 846,000 $3.27M 0.63% 0.27% 2026-03-31
25 DRIEHAUS CAPITAL MANAGEMENT LLC 793,773 $3.07M 0.59% 0.25% 2026-03-31
6 filers$5.36M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $2.03M 37.84% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $1.36M 25.34% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $924.16K 17.25% 2026-03-31
4 Point72 Asset Management, L.P. $377.32K 7.04% 2026-03-31
5 HAP TRADING, LLC $350.62K 6.54% 2025-09-30
6 Cubist Systematic Strategies, LLC $320.77K 5.99% 2025-09-30
6 filers$7.05M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $5.80M 82.31% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $335.14K 4.75% 2026-03-31
3 SIMPLEX TRADING, LLC Custodian $323.53K 4.59% 2026-03-31
4 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $274.38K 3.89% 2026-03-31
5 CITADEL ADVISORS LLC Custodian $236.46K 3.35% 2026-03-31
6 GROUP ONE TRADING LLC Custodian $77.79K 1.10% 2026-03-31
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio68.0
P/S Ratio43.6
EV/EBITDA-16.9
TTM Revenue$0.0B
TTM Net Income$-0.4B
TTM EPS$-1.18
ROE-1894.8%
Debt/Equity4.62